Last updated on: 23/11/2018
1. Contact details
Name of data sourceEFEMERIS
Name under which the data source should be displayed in the inventory (e.g short name if one exists)EFEMERIS
Name of organisation
1) Department/research groupPharmacoepidemiology research team
2) Organisation/affiliationUniversity of Toulouse 3 and INSERM 1027
Administrative Contact
Title Dr
Last name Damase-Michel
First name Christine
Address line 1Pharmacologie
Address line 2Faculté de Médecine
Address line 337 Allees Jules Guesde
CityToulouse
Postcode31000
CountryFrance
Scientific Contact
Title Dr
Last name Damase-Michel
First name Christine
Address line 1Pharmacologie
Address line 2Faculté de Médecine
Address line 337 Allees Jules Guesde
CityToulouse
Postcode31000
CountryFrance
2. Description/category
Administrative database, e.g. claims database
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
Vaccines
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
Teratogenic events
Yes
premature births, birth defects, neonatal pathology, health status of the child at birth, 9 months and 24 months
Specific event
Description: Neuro-psychomotor development of children at 9 and 24 months can also be available.
No
Neuro-psychomotor development
5. Year of establishment
2004
6. Geographical origin of data
EEA/EFTA countries
France
7. Demographical extent of data collection
Regional sub-set :
departement of Haute-Garonne, South West France
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
18 to 45 years
46 to 64 years
9. Size of the source/catchment population
130,000
10 a. Total (cumulative) number of persons with actual data
130,000
10 b. Number of persons with active data collection in past calendar year
10,000
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
after anonymization on name, surname and date of birth
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database.
Foch C, Araujo M, Weckel A, Damase-Michel C, Montastruc JL, Benevent J, Durrieu G, Lacroix I.
Int J Pediatr Otorhinolaryngol. 2018 Oct;113:192-197.www.efemeris.fr
Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort. Hurault-Delarue C, Lacroix I, Bénard-Laribière A, Montastruc JL, Pariente A, Damase-Michel C. Eur Arch Psychiatry Clin Neurosci. 2018 May 26.www.efemeris.fr
A contemporary description of French newborns' growth using the Efemeris cohort. Beau AB, Tauber M, Chollet C, Hurault-Delarue C, Bouilhac C, Montastruc JL, Lacroix I, Damase-Michel C. Arch Pediatr. 2017 May;24(5):424-431.www.efemeris.fr
Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics. Hurault-Delarue C, Chouquet C, Savy N, Lacroix I, Beau AB, Montastruc JL, Damase-Michel C. Pharmacoepidemiol Drug Saf. 2017 May;26(5):561-569. www.efemeris.fr
Prescription of asthma medications before and during pregnancy in France: An observational drug study using the EFEMERIS database. Beau AB, Didier A, Hurault-Delarue C, Montastruc JL, Lacroix I, Damase-Michel C. J Asthma. 2017 Apr;54(3):258-264.www.efemeris.fr
